GlassScriptPhysician profile
Gary P Harvey
NPI 1962457663
$1,404.90
in general payments reported to CMS, 2019-2025
15 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $51.23 · 2021: $377 · 2022: $72.44 · 2023: $285 · 2024: $14.38 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $526.40 | 2019-2023 | Altis |
| Intuitive Surgical, INC. | $277.52 | 2020-2025 | |
| Innovation Technologies INC | $99.30 | 2023 | Irrisept |
| Ethicon US, LLC | $82.16 | 2021-2022 | |
| Astellas Pharma US INC | $77.80 | 2021-2025 | Veozah |
| Abbvie INC. | $59.14 | 2019-2021 | |
| Novo Nordisk INC | $58.85 | 2023 | |
| Caldera Medical, INC | $52.00 | 2021 | |
| Sumitomo Pharma America, INC. | $38.13 | 2025 | Gemtesa |
| Coopersurgical, INC. | $33.08 | 2020-2022 | |
| Exeltis, USA INC. | $30.86 | 2022-2024 | Slynd |
| Therapeuticsmd, INC. | $28.35 | 2019 | |
| Axonics, INC. | $15.94 | 2023 | Bulkamid |
| Merck Sharp & Dohme LLC | $13.23 | 2019 | |
| Eisai INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.